期刊
DALTON TRANSACTIONS
卷 42, 期 48, 页码 16733-16741出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c3dt51382c
关键词
-
资金
- Australian Research Council [DP110103812]
- Monash University
- Quaid-i-Azam University
- Higher Education Commission of Pakistan [20-1826/NRPU/RD]
- Pakistan Government
In seeking new drugs for the treatment of the parasitic disease Leishmaniasis, an extensive range of organometallic antimony(V) dicarboxylates of the form [SbR3(O2CR')(2)] have been synthesised, characterised and evaluated. The organometallic moieties (R) in the complexes vary in being Ph, tolyl (o, m or p), or benzyl. The carboxylates are predominantly substituted benzoates with some compounds incorporating acetato or cinnamato ligands. The crystal structures of [Sb(p-Tol)(3)(O2CC6H2-3,4,5-(OMe)(3))(2)]center dot 0.5PhMe and [SbPh3(m-CH3C6H4CH2CO2)(2)] were determined and shown to adopt a typical trigonal pyramidal geometry, being monomeric with a five coordinate Sb centre. In total, the biological activity of 26 Sb(V) compounds was assessed against the Leishmania major parasite, and also human fibroblast skin cells to give a measure of general toxicity. Of these, 11 compounds (predominantly substituted benzoates with m-or p-tolyl ligands) proved to be highly effective against the parasite amastigotes at concentrations of 0.5-3.5 mu M, while being non-toxic towards the mammalian cells at levels below 25 mu M, making them highly promising drug candidates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据